GAMMA Investing »

Amylyx Pharmaceuticals shares owned by GAMMA Investing

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7k 125 13.59
2024-03-31 $99 35 2.83
2023-12-31 $560 35 16.00

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc Cl A Common Stock (META)
Jpmorgan Chase Common Stock (JPM)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Tesla Common Stock (TSLA)
Ishares Inc Core Msci Emkt Etf (IEMG)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Ishares Tr Shrt Nat Mun Etf Etf (SUB)
Visa Inc Com Cl A Common Stock (V)
Ishares Tr National Mun Etf Etf (MUB)

View all positions for GAMMA Investing

Top funds holding Amylyx Pharmaceuticals

FMR
Perceptive Advisors
BlackRock
Adage Capital Partners GP
TCG Crossover Management
Vanguard Group
Saturn V Capital Management
Commodore Capital
First Light Asset Management
Point72 Asset Management
Henderson Group
Driehaus Capital Management
Almitas Capital
Goldman Sachs Group
Paradigm Biocapital Advisors

View all funds holding Amylyx Pharmaceuticals